The effects of vildagliptin compared with metformin on vascular endothelial function and metabolic parameters: a randomized, controlled trial (Sapporo Athero-Incretin Study 3)

BACKGROUND: Dipeptidyl peptidase-4 (DPP-4) inhibitors may have protective effects in the early stage of atherosclerosis in patients with type 2 diabetes, although similar effects in advanced atherosclerosis were not shown in recent randomized placebo-controlled studies. Therefore, we investigated th...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Cardiovasc Diabetol
Autori principali: Kitao, Naoyuki, Miyoshi, Hideaki, Furumoto, Tomoo, Ono, Kota, Nomoto, Hiroshi, Miya, Aika, Yamamoto, Chiho, Inoue, Atsushi, Tsuchida, Kenichi, Manda, Naoki, Kurihara, Yoshio, Aoki, Shin, Nakamura, Akinobu, Atsumi, Tatsuya
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2017
Soggetti:
Original Investigation
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5634845/
https://ncbi.nlm.nih.gov/pubmed/29017497
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12933-017-0607-6
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi